Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro

被引:71
作者
Li, H [1 ]
Cao, Y [1 ]
Berndt, MC [1 ]
Funder, JW [1 ]
Liu, JP [1 ]
机构
[1] Baker Med Res Inst, Mol Signalling Lab, Prahran, Vic 3181, Australia
基金
英国医学研究理事会;
关键词
telomerase reverse transcriptase (TERT); telomerase-associated protein 1 (TEP1); p53; telomerase inhibitory polypeptide 1 (TEIPP1); breast cancer cells;
D O I
10.1038/sj.onc.1203061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The telomere DNA polymerase (telomerase) and the tumor suppressor protein p53 are frequently associated with human cancers, and activation of telomerase and inactivation of p53 involved in cancer cell immortalization. In this report, we demonstrate a direct interaction of telomerase with p53 in the nuclear lysates of human breast cancer cells, and with recombinant human p53, by affinity chromatography and immunoprecipitation. On activity criteria, the interaction is between the carboxyl-terminal region of p53 and a region close to the amino-terminus of human telomerase-associated protein 1 (hTEP1). Incubation of recombinant p53 with nuclear telomerase extracts results in inhibition of telomerase activity, with the C-terminal region of p53 being essential for inhibition. This effect is not mediated by binding to telomerase substrate DNA, but requires the region near the N-terminus of hTEP1, in that a synthetic peptide derived from this region of hTEP1 similarly inhibits telomerase activity. Together, these in vitro interactions between telomerase and p53 suggest that the activity of telomerase may be regulated by p53, downregulation of which in turn would favor up-regulation of telomerase activity in cancer cell development.
引用
收藏
页码:6785 / 6794
页数:10
相关论文
共 50 条
  • [21] Clinical applications of detecting dysfunctional p53 tumor suppressor protein
    Baas, IO
    Hruban, RH
    Offerhaus, GJA
    HISTOLOGY AND HISTOPATHOLOGY, 1999, 14 (01) : 279 - 284
  • [22] Refolding and structural characterization of the human p53 tumor suppressor protein
    Bell, S
    Hansen, S
    Buchner, J
    BIOPHYSICAL CHEMISTRY, 2002, 96 (2-3) : 243 - 257
  • [23] The role of p53 tumor-suppressor protein in apoptosis and cancerogenesis
    Maximov, G. K.
    Maximov, K. G.
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2008, 22 (02) : 664 - 668
  • [24] p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
    V. Marcel
    P. Hainaut
    Cellular and Molecular Life Sciences, 2009, 66
  • [25] p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
    Marcel, V.
    Hainaut, P.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (03) : 391 - 406
  • [26] p53 tumor suppressor protein overexpression in osteogenic tumors of dogs
    Sagartz, JE
    Bodley, WL
    Gamblin, RM
    Couto, CG
    Tierney, LA
    Capen, CC
    VETERINARY PATHOLOGY, 1996, 33 (02) : 213 - 221
  • [27] POSTTRANSLATIONAL REGULATION OF P53 TUMOR-SUPPRESSOR PROTEIN FUNCTION
    MAXWELL, SA
    ROTH, JA
    CRITICAL REVIEWS IN ONCOGENESIS, 1994, 5 (01): : 23 - 57
  • [28] Protein methylation: a new mechanism of p53 tumor suppressor regulation
    Scoumanne, A.
    Chen, X.
    HISTOLOGY AND HISTOPATHOLOGY, 2008, 23 (09) : 1143 - 1149
  • [29] P53 - THE ULTIMATE TUMOR SUPPRESSOR GENE
    OREN, M
    FASEB JOURNAL, 1992, 6 (13) : 3169 - 3176
  • [30] The role of the tumor suppressor p53 in spermatogenesis
    Tim L Beumer
    Hermien L Roepers-Gajadien
    Iris S Gademan
    Paul PW van Buul
    Gabriel Gil-Gomez
    Derek H Rutgers
    Dirk G de Rooij
    Cell Death & Differentiation, 1998, 5 : 669 - 677